Moderna’s stock jumps after biotech raises sales outlook
The company lifted its revenue outlook for the year, saying it expects revenue to grow as much as 25% in 2026.
We haven't written up this one. MarketWatch Top has the full story — the link below goes straight to it.
This story
This is one outlet's version. Read the fullest account.
- Moderna’s stock jumps after biotech raises sales outlook marketwatch.com